Clinical Trial

Multicenter Prospective Non-randomized Controlled Study of ALA-PDT for LSIL With HPV16/18 Infection

Study acronym: PDT for LSIL
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This multicenter, prospective trial assesses ALA-PDT versus observation for efficacy and safety in treating cervical LSIL with HPV16/18 infection.
Protocol Amendment History 1 change
notable Sponsor changed: Second Affiliated Hospital, School of Medicine, Zhejiang University -> Second Affiliated Hospital, Zhejiang University, School of Medicine 2026-08-09
Trial Details
NCT Number NCT07306247
Lead Sponsor Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborators: Women's Hospital School Of Medicine Zhejiang University, First People's Hospital of Hangzhou, First Affiliated Hospital of Ningbo University, Shaoxing People's Hospital, Linping First People's Hospital
Conditions HPV-16/18, Photodynamic Therapy (PDT), LSIL, Low Grade Squamous Intraepithelial Lesion
Enrollment 225 participants
Start Date 2026-01
Primary Completion 2027-01 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-29